MedPath

Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment

Phase 1
Completed
Conditions
Intervention
Psychotic Disorders
Marijuana Abuse
Interventions
Behavioral: Social competence Training
Behavioral: Cannabis-Consumption-Reduction-Training
Registration Number
NCT00783185
Lead Sponsor
University of Konstanz
Brief Summary

Intention of the study is to examine, if the symptomatology of dual diagnosis patients is less severe after a special indication training for reduction of cannabis consumption in comparison to unspecified trainings.

Point of interest is psychopathology and consumerism.

Detailed Description

Dual diagnosis patients (psychosis and cannabis abuse) account for more clinical admissions than single diagnosis patients.

Cannabis misuse is a known risk factor for recurrence of psychosis.

A specified intervention on the basis of a manual for schizophrenic substance abusers is administered to inpatients in a specialized unit for young schizophrenic patients in a psychiatric hospital.

The control group, same indication (psychotic disorder and cannabis misuse) receives social competence training (specified for schizophrenic patients as well).

Admission to groups is randomly.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Clinical diagnosis of schizophrenia and disorders with psychotic features
  • Misuse of cannabis during 12 months preceding admission to hospital
Exclusion Criteria
  • Not able to attend training twice a week for 45 minutes (concentration, attention, psychotic symptoms, agitation)
  • Discharge from hospital before completion of training

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CGSocial competence TrainingControl group
ACTCannabis-Consumption-Reduction-TrainingAnti-Cannabis-Consumption-Training
Primary Outcome Measures
NameTimeMethod
PANSS Positive and Negative Symptom Scalepost intervention, six months follow-up
Secondary Outcome Measures
NameTimeMethod
Urinstatus for cannabinoidsweekly during and post intervention, follow-up

Trial Locations

Locations (1)

University of Konstanz

🇩🇪

Konstanz, Baden-Württemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath